USE OF GLP-1 OR ANALOGS AND DERIVATIVES THEREOF FOR PREPARATION OF PHARMACEUTICAL COMPOSITIONS AS AGENTS IN REDUCING MORBIDITY AND MORTALITY OF MYOCARDIAL INFARCTION

摘要

This invention provides a method of reducing mortality and morbidity after myocardial infarction. GLP-1, a GLP-1 analog, or a GLP-1 derivative, is administered at a dose effective to normalize blood glucose.